Palvella Therapeutics, Inc. ( PVLA) - Stock Earnings
PVLA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
PVLA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -12.7 million USD | — USD |
| 2026Q1 | -15.8 million USD | — USD |
| 2026Q2 | -21.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PVLA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 18.7 million USD | — USD |
| 2024 | -17.4 million USD | — USD |
| 2025 | -41.7 million USD | — USD |
| 2026 Est. | — | — |
PVLA
Price: $125.89
52 week price:
Earnings Per Share: -4.69 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.9 billion